Tommie Reerink

Stock Analyst at Goldman Sachs

(1.50)
# 3,291
Out of 4,876 analysts
3
Total ratings
66.67%
Success rate
-1.03%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Tommie Reerink

Atara Biotherapeutics
Jul 17, 2024
Maintains: Sell
Price Target: $13$11
Current: $7.96
Upside: +38.19%